BioNTech SE

NAS:BNTXHealthcareNASDAQ:NBInasdaq_composite

$89.21+1.71%At closeAt close · Tue 20 Oct · ≈ AED 327.62 · Market cap $22.41B · Next earnings Tue 3 Nov · Extended $89.03 −0.20%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	87.7%	84.7%	82.7%	84.3%	80.3%	77.6%	—	—
Operating margin	−17.1%	80.5%	73.0%	18.1%	−47.8%	−22.6%	−22.6%	+0.0 pts
Net margin	3.2%	54.2%	54.5%	24.4%	−24.2%	−39.6%	−39.6%	+0.0 pts
EBITDA margin	−21.8%	79.1%	75.7%	36.1%	−13.3%	−22.8%	—	—
Return on equity	1.1%	86.5%	47.0%	4.6%	−3.4%	−5.7%	−5.7%	+0.0 pts
Return on assets	0.7%	65.0%	40.5%	4.0%	−3.0%	−5.0%	−5.0%	+0.0 pts
Return on capital employed	−4.8%	123.8%	62.2%	3.3%	−6.6%	−3.1%	—	—
Debt / equity	0.2×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	10.4%	1.9%	0.9%	1.0%	1.1%	1.2%	—	—
Interest coverage	−44.2×	2,715.1×	799.1×	89.0×	−99.9×	−45.7×	—	—
Current ratio	2.8×	4.3×	7.4×	9.4×	7.5×	7.5×	7.5×	+0.0%
Quick ratio	2.6×	4.2×	7.3×	9.3×	7.3×	7.5×	—	—
Cash ratio	2.0×	0.5×	4.7×	5.6×	3.9×	3.6×	3.6×	+0.0%
Asset turnover	0.2×	1.2×	0.7×	0.2×	0.1×	0.1×	—	—
Inventory turnover	0.9×	5.8×	6.8×	1.7×	1.9×	5.6×	—	—
Receivables turnover	2.9×	1.5×	2.4×	1.6×	1.8×	2.8×	—	—
Dividend payout	0.0%	0.0%	5.1%	0.0%	0.0%	0.0%	—	—